A new chitosan-coated vaccine delivery system reduced fish mortality from 78% to 18% when Nile tilapia were exposed to bacterial infection, according to a 2026 study of 315 fish. The special coating protects the vaccine as it passes through the fish’s digestive system, allowing oral vaccination to work nearly as well as injection-based vaccines. Gram Research analysis shows this approach achieved a 76.9% protection rate, suggesting oral vaccines could become practical for protecting farmed fish without individual injections.
Scientists tested a new way to deliver vaccines to farmed fish by mouth instead of injection. They coated tiny fat bubbles called liposomes with a natural material called chitosan to protect a vaccine against a harmful bacteria. According to Gram Research analysis, fish that received this special coated vaccine showed much stronger immune responses and survived better when exposed to the disease. This discovery could help fish farmers protect millions of fish more easily and cheaply than current methods.
Key Statistics
A 2026 research study of 315 tilapia fish found that chitosan-coated liposomal oral vaccines reduced cumulative mortality to 18% compared to 78% in unvaccinated controls, achieving a relative protection rate of 76.9%.
The chitosan-coated liposomal vaccine formulation achieved 44.22% protein encapsulation efficiency and produced the strongest antibody response against Streptococcus agalactiae bacteria in vaccinated fish.
Fish receiving the chitosan-coated liposomal vaccine showed markedly reduced tissue damage in the brain, eye, and spleen compared to unvaccinated fish following bacterial challenge in a 2026 study.
The Quick Take
- What they studied: Whether coating tiny fat bubbles with a natural shell material could make an oral fish vaccine work better by protecting it as it travels through the fish’s digestive system
- Who participated: 315 Nile tilapia fish divided into seven groups, some receiving different vaccine formulations and some receiving no vaccine as a control
- Key finding: Fish receiving the chitosan-coated liposomal vaccine had only 18% mortality after disease exposure compared to 78% in unvaccinated fish, with a protection rate of 76.9%
- What it means for you: This research suggests oral vaccines could become a practical way to protect farmed fish from bacterial infections without individual injections, potentially reducing disease losses in aquaculture. However, this study was done in fish, so results may not directly apply to other animals or humans.
The Research Details
Researchers divided 315 tilapia fish into seven different groups. One group ate normal food without any vaccine. Other groups received different types of vaccine delivery systems: plain vaccine, empty protective carriers, fat bubbles called liposomes, chitosan particles (a natural material from shellfish shells), or the new combination of chitosan-coated liposomes. Fish were fed the vaccine for 10 days, then given a booster dose 20 days later. The scientists measured how well each vaccine worked by checking the fish’s immune response, their growth, their survival when exposed to the disease, and damage to their organs.
The key innovation was coating the liposomes with chitosan, a natural polymer that comes from shellfish shells. This coating protects the vaccine as it passes through the fish’s stomach and intestines, where stomach acid and digestive enzymes would normally destroy it. The coating also helps the vaccine particles stick to and be absorbed by the intestinal lining, which is where the immune system can recognize and respond to the vaccine.
Oral vaccination is much easier than injecting thousands of fish individually. A farmer can simply add vaccine to the fish food and feed it to the entire population at once. However, the digestive system is harsh and breaks down most vaccines before they can work. This study tested whether special protective coatings could solve that problem, making oral vaccination practical for fish farming.
This was a controlled experiment with random assignment of fish to different groups, which is a strong research design. The researchers measured multiple outcomes including immune markers, growth, survival, and tissue damage to get a complete picture. However, the study was conducted only in one fish species under laboratory conditions, so results may differ in real farm settings. The researchers also noted they didn’t directly measure how the vaccine moved through the digestive system or how much actually got absorbed, which would strengthen future studies.
What the Results Show
The chitosan-coated liposomal vaccine performed best among all formulations tested. Fish receiving this vaccine developed the strongest immune response, with higher levels of specific antibodies (IgM) against the bacteria compared to all other groups. These fish also had higher levels of protective molecules called antioxidants in their blood.
When researchers exposed vaccinated fish to the actual disease, the results were dramatic. Fish that received the chitosan-coated liposomal vaccine had only 18% mortality, meaning 82% survived. In contrast, unvaccinated control fish had 78% mortality. This represents a relative protection rate of 76.9%, meaning the vaccine prevented about 77% of the deaths that would have occurred without it.
Beyond survival, vaccinated fish showed much less damage to their organs. Brain tissue, eye tissue, and spleen tissue all showed fewer signs of infection and inflammation in the vaccinated group compared to unvaccinated fish. The vaccine also appeared to boost the fish’s overall antioxidant defenses, which help protect cells from damage.
The chitosan coating improved the vaccine’s physical properties significantly. The coated liposomes successfully enclosed 44.22% of the vaccine protein, which was higher than the other delivery systems tested. The coating also gave the particles a positive electrical charge, which helps them stick to the negatively charged intestinal lining and be absorbed more effectively. Gene expression studies showed that vaccinated fish had increased activity of immune-related genes, though the response varied depending on which specific gene was measured and which formulation was used.
This research builds on earlier work showing that oral vaccines can work in fish if the vaccine is properly protected. Previous studies showed that plain vaccines given by mouth don’t work well because digestive enzymes destroy them. This study demonstrates that chitosan coating significantly improves on earlier liposome-only approaches, suggesting that combining multiple protective strategies works better than using just one. The protection rate of 76.9% is competitive with or better than injection-based vaccines reported in other fish studies.
The researchers acknowledged several important limitations. First, they couldn’t completely separate the effects of the protective coating itself from the effects of having more vaccine particles actually delivered to the immune system, since different formulations had different encapsulation efficiencies. Second, they didn’t directly measure how the vaccine moved through the digestive system or how much was actually absorbed by the intestines. Third, the study was conducted in laboratory conditions with controlled fish populations, so results might differ in actual fish farms with different water conditions, fish densities, and feeding practices. Finally, this was tested only in one fish species, so results may not apply to other farmed fish like salmon or catfish.
The Bottom Line
For fish farmers: This research suggests that chitosan-coated liposomal oral vaccines could become a practical alternative to injection-based vaccines for protecting tilapia from bacterial infections. The strong evidence from this controlled study supports considering this approach, though field trials in actual farm conditions would be valuable before full adoption. Confidence level: Moderate to High for tilapia specifically; Lower for other fish species until similar studies are completed.
Fish farmers raising tilapia or similar species should pay attention to this research as it could reduce disease losses and labor costs. Aquaculture companies developing vaccines should consider this technology. Researchers studying oral vaccines in other animals may find the chitosan-coating approach useful. This research is less directly relevant to people raising other types of animals or to human medicine, though the coating technology might eventually be adapted for other uses.
In this study, fish were vaccinated for 10 days, received a booster 20 days later, and showed strong protection within a few weeks. In practical farm settings, farmers could expect to see disease protection develop over a similar timeframe, though this would need to be confirmed in real-world conditions. The benefits would likely persist for several months, though the duration of immunity was not tested in this study.
Frequently Asked Questions
How much better does the chitosan-coated vaccine work compared to regular oral vaccines in fish?
The chitosan-coated vaccine reduced fish mortality to 18% versus 78% in unvaccinated fish, achieving 76.9% protection. This represents a dramatic improvement over plain oral vaccines, which typically fail because digestive enzymes destroy the vaccine before it can work.
Can this coating technology be used for vaccines in other animals besides fish?
This study tested only tilapia, so results may not apply to other fish species or animals yet. However, the chitosan-coating approach is based on general principles of protecting vaccines from digestive breakdown, so researchers are exploring similar strategies for other species. More research would be needed to confirm effectiveness elsewhere.
How long does the protection from this oral vaccine last in fish?
This study showed strong protection within weeks of vaccination and booster dosing, but didn’t measure how long immunity persists over months or years. Fish farmers would need to monitor disease rates over extended periods to determine if annual revaccination or other schedules are necessary.
Why is oral vaccination better than injecting fish with vaccines?
Injecting hundreds of thousands of fish individually is labor-intensive and stressful for the fish. Oral vaccination can be added to feed and given to entire populations at once, making it much faster and cheaper. This new coating makes oral vaccines actually work by protecting them from stomach acid.
What is chitosan and where does it come from?
Chitosan is a natural material derived from shellfish shells, particularly shrimp and crab shells. It’s biodegradable, safe, and has been used in medical applications for decades. When used as a coating, it protects vaccines from digestive breakdown while helping them stick to intestinal tissue.
Want to Apply This Research?
- If using an aquaculture management app, track vaccination dates, mortality rates, and disease signs in different fish populations. Compare groups receiving oral vaccines versus injection vaccines to monitor real-world effectiveness and identify any differences in disease outbreak timing or severity.
- Fish farmers could implement oral vaccination protocols by adding vaccine-coated feed to their feeding schedules on specific dates, then monitoring fish health and survival over the following weeks. Set reminders for booster vaccinations at appropriate intervals and record any disease outbreaks or unusual fish behavior.
- Establish baseline mortality and disease rates before vaccination, then track these metrics weekly for at least 8-12 weeks after vaccination. Compare vaccinated and unvaccinated populations side-by-side. Monitor for any unexpected side effects or changes in fish growth rates. Document water quality parameters and feeding practices to identify factors that might affect vaccine effectiveness.
This research was conducted in fish (Nile tilapia) under controlled laboratory conditions and has not been tested in humans or other animal species. Results from fish studies may not directly apply to other animals or to human medicine. Fish farmers considering implementing oral vaccination programs should consult with aquaculture veterinarians and conduct field trials appropriate to their specific conditions before widespread adoption. This summary is for informational purposes and should not replace professional veterinary or agricultural advice. Always follow local regulations regarding fish health management and vaccination protocols.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.